Testing for Multiple Myeloma Risk Stratificationmicroarray-based_gene_expression_profile_testing_for_multiple_myeloma 9/2013 3/2015 3/2016 3/2015 Microarray-based gene expression profile analysis has been proposed as a means to risk-stratify patients with multiple myeloma to guide treatment decisions. ...
By combining genomic testing and next generation sequencing technology, a new partnership aims to advance predictive tests for multiple myeloma (MM). Dr Siobhan Glavey, RSCI Multiple myeloma is a cancer of plasma cells in the bone marrow that normally produce antibodies to help fight infection. A...
A MSherrod, PHari, C AMosse, R CWalker, R FCornell. (2015) Minimal residual disease testing after stem cell transplantation for multiple myeloma. Bone Marrow Transplantation /A M Sherrod, P Hari, C A Mosse, R C Walker, R F Cornell. (2015) Minimal residual disease testing after stem ...
For example, factors that increase the risk of afalse positivefor a vitamin B12 deficiency include: Multiple myeloma, a cancer of certain white blood cells HIV infection Pregnancy Use of oral contraception Use of the anticonvulsant drug phenytoin Other factors may cause your vitamin B12 levels to ...
David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASS-FIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the blood proteins, for improved patient care and simpler t...
limitation that may be overcome by testing for cfDNA [140]. The same limitation applies to plasma cell myeloma where bone marrow involvement is often spatially heterogeneous. This limitation also applies to multi-site involvement in lymphomas. These situations parallel the concept of testing blood ...
These facts suggest that monitoring the immune response to vaccination in patients with multiple myeloma might provide guidance for the administration of additional doses of the same or another vaccine, or even treatment discontinuation [69]. Overall, clearly, the subtype of hematologic malignancy and...
(October 29, 2015) International Myeloma Working Group (IMWG) Criteria for the Diagnosis of Multiple Myeloma. Available online at https://imwg.myeloma.org/international-myeloma-working-group-imwg-criteria-for-the-diagnosis-of-multiple-myeloma/. Accessed on 7/11/2018. ...
A New Prognostic Scoring System for Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma Multiple myeloma (MM) is a heterogeneous disease in the survival outcome due to the differences ...
Overview of Bispecifics for R/R Multiple Myeloma Patient Profile: A 72-Year-Old Man With RRMM Future Treatment Landscape for EGFR-mutated Non-Small Cell Lung Cancer Adverse Event Management: Amivantamab MARIPOSA-2: Second-Interim Survival Data Mechanisms of Acquired Resistance in First-Line Treatme...